Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T16:36:20.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study record content with an access-denied page. This means users cannot view the trial details on that URL, and the site presents a generic error instead of the study information.
    Difference
    0.5%
    Check dated 2026-09-26T18:47:36.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays a 403 error and the trial content is no longer visible, changing how users access information about the INITIATE study.
    Difference
    18%
    Check dated 2026-09-19T17:45:17.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, signaling a minor update to the page version. This does not alter the study details or other visible content.
    Difference
    0.1%
    Check dated 2026-08-29T19:18:40.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page's revision label advanced from v3.6.4 to v3.6.5, indicating a new version of the page's metadata for the study record. This reflects an update to the page documentation rather than substantive changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-08T10:53:20.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page shows a revision label updated from v3.6.3 to v3.6.4, signaling a new release of the site's software rather than a modification to trial data.
    Difference
    0.1%
    Check dated 2026-07-25T05:18:54.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.